Indian markets endured another choppy day on Tuesday, with Nifty inching up 0.1% to 25,480 and Sensex flat at 83,150, as mixed Q3 results from chemicals offset drags from realty amid lingering FII caution (₹800 Cr net sell). Highlighting the session's whipsaw action, 5 scrips oscillated to touch both upper and lower price bands (mostly 2-5%), driven by low-float speculation and rapid sentiment flips in BE/BZ series. This mirrors ongoing January turbulence, with Manakaluco (down 5% to ₹61.64 after intra-day volatility), Vivimedlab (up 1.8% to ₹8.31 on pharma rebound bets), and Mep (down 1.9% to ₹1.59 amid funding woes) exemplifying the erratic trades, totaling modest ₹2.3 Cr in value.
The dual hits signal opportunistic buying in penny stocks amid thin volumes, without clear catalysts but tied to earnings anxiety. Advancers slightly led decliners 1.1:1, with overall turnover down 8%. Analysts see this as short-term noise—potential stabilization if global cues firm up.
Top Dual Band Swingers (Sorted by Traded Value)
Snapshot of the volatile names that hit both ceilings and floors, per BSE/NSE:
| Rank | Stock Name | Series | LTP (₹) | % Change | Price Band (%) | Volume (Lakh Shares) | Traded Value (₹ Cr) |
|---|---|---|---|---|---|---|---|
| 1 | Manakaluco | BE | 61.64 | -4.99 | 5.00 | 3.36 | 2.24 |
| 2 | Vivimedlab | EQ | 8.31 | 1.84 | 5.00 | 19.02 | 1.55 |
| 3 | Mep | BZ | 1.59 | -1.85 | 2.00 | 0.74 | 0.01 |
| 4 | Sitinet | BZ | 0.36 | 2.86 | 2.00 | 1.62 | 0.01 |
| 5 | Ansalapi | BZ | 3.13 | -1.88 | 2.00 | 0.12 | 0.00 |
Key Highlights:
- Manakaluco's Alum Agony: The metal firm swung 5% bands to end down 5% at ₹61.64, trading ₹2.24 Cr amid input cost spikes—volumes doubled.
- Vivimedlab's Pharma Flip: Up 1.8% to ₹8.31 after dual touches, buoyed by export order rumors; ₹1.55 Cr turnover in volatile session.
- Mep's Funding Fumble: Down 1.9% to ₹1.59 post-swings, hit by liquidity concerns in infra; penny play with minimal ₹0.01 Cr value.
- Penny Volatility: Sitinet (+2.9% to ₹0.36) and Ansalapi (-1.9% to ₹3.13) highlighted low-cap frenzy in BZ series.
Speculators may chase rebounds, but risks remain if earnings underwhelm. Nifty support at 25,300—watch chemical results for direction. BSE/NSE data; bands in effect.
